SEB Asset Management’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.36M Buy
14,459
+217
+2% +$76.6K 0.02% 438
2026
Q2
$5.11M Buy
14,242
+764
+6% +$234K 0.02% 463
2026
Q1
$3.38M Buy
+13,478
New +$3.35M 0.01% 516

Other funds holding WST

SEB Asset Management's WST Position: Q3 2026 in Review

SEB Asset Management increased its West Pharmaceutical (WST) stake by 1.5% in Q3 2026, buying an estimated $76.6K and bringing the position to 14,459 shares worth $5.36M. The position accounts for 0.02% of the portfolio, ranked #438.

SEB Asset Management first reported a position in WST in Q1 2026 and has held it in 3 quarters since. 881 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • SEB Asset Management held 14,459 shares of West Pharmaceutical worth $5.36M as of Q3 2026.
  • SEB Asset Management bought 217 West Pharmaceutical shares in Q3 2026, an estimated $76.6K.
  • West Pharmaceutical made up 0.02% of SEB Asset Management's portfolio in Q3 2026, its #438 holding.
  • SEB Asset Management first reported a position in West Pharmaceutical in Q1 2026 and has held it in 3 quarters since.
  • 881 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on SEB Asset Management's 13F filing for Q3 2026, filed 4 Nov 2026.